about
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaTargeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.Molecular therapeutic approaches for pediatric acute myeloid leukemia.Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cellsBreastfeeding, Other Early Life Exposures and Childhood Leukemia and Lymphoma.Spectrum of diseases diagnosed on bone marrow examination of 285 infants in a single tertiary care center.Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia
P2860
Q26781328-E295BD03-D34A-4D14-9F6E-0B0CB147AF0DQ34416178-50CD59E0-ED85-4964-9045-524CC658ABA5Q37643136-E95065E0-F9D0-4F2B-AA38-CF731B45CE51Q42317471-BB095710-336C-4834-95B4-C9A47DC547C4Q47546650-5D0DC5CF-0B22-41CE-A899-13D08EE1BABBQ50645853-B976592E-2E35-49FD-A8D9-4A258F7EED9DQ57138588-0B445ED7-CF28-4904-AC95-7D44E0A57BEA
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Treatment of infant leukemias: challenge and promise.
@ast
Treatment of infant leukemias: challenge and promise.
@en
type
label
Treatment of infant leukemias: challenge and promise.
@ast
Treatment of infant leukemias: challenge and promise.
@en
prefLabel
Treatment of infant leukemias: challenge and promise.
@ast
Treatment of infant leukemias: challenge and promise.
@en
P2860
P1476
Treatment of infant leukemias: challenge and promise.
@en
P2093
Patrick Brown
P2860
P304
P356
10.1182/ASHEDUCATION-2013.1.596
P577
2013-01-01T00:00:00Z